JNJ vs PFE
By Alex · Tickerpine
Johnson & Johnson vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | PFE |
|---|---|---|
| Price | $263.81 | $30.03 |
| Market cap | $635.07B | $171.16B |
| P/E ratio | 40.0 | 39.5 |
| ROE | 20.02% | 5.01% |
| Profit margin | 16.20% | 6.80% |
| Revenue growth | 5.90% | 2.60% |
| Dividend yield | 2.03% | 5.73% |
| Beta | 0.21 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs PFE in plain English
- JNJ is the bigger company — about 3.7× the market cap of PFE.
- PFE is cheaper on earnings (P/E 39.5 vs 40.0).
- JNJ earns a higher return on equity (20% vs 5%).
- JNJ is growing revenue faster (6% vs 3%).
- PFE has the higher dividend yield (5.73% vs 2.03%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.